Daniel Palacios

Follow

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 12,122,761
- Issue date Oct 22, 2024
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,820,778
- Issue date Nov 21, 2023
- Novartis AG
- Amy Calhoun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,548,865
- Issue date Jan 10, 2023
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-azaspiro[3.4]octane derivatives as M4 agonists
- Patent number 11,485,742
- Issue date Nov 1, 2022
- Novartis AG
- Amy Calhoun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives and uses thereof
- Patent number 10,654,828
- Issue date May 19, 2020
- Novartis AG
- John Ryan Kerrigan
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20230212139
- Publication date Jul 6, 2023
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20220411435
- Publication date Dec 29, 2022
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210130365
- Publication date May 6, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
- Publication number 20210107889
- Publication date Apr 15, 2021
- Novartis AG
- Amy CALHOUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLE DERIVATIVES AND USES THEREOF
- Publication number 20190055219
- Publication date Feb 21, 2019
- Novartis AG
- John Ryan Kerrigan
- C07 - ORGANIC CHEMISTRY